Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach
M P Mourits, L Koornneef, W M Wiersinga, M F Prummel, A Berghout, R van der Gaag, M P Mourits, L Koornneef, W M Wiersinga, M F Prummel, A Berghout, R van der Gaag
Abstract
Patients with serious inflammatory Graves' ophthalmopathy should be treated with anti-inflammatory drugs or radiotherapy to prevent complications like fibrosis, while those with non-inflammatory ophthalmopathy may be treated by surgery immediately. It is often difficult, however, to distinguish inflammatory from non-inflammatory Graves' disease. We therefore present a simple clinical classification here to differentiate between these two conditions. This classification is based on the classical signs of inflammation--pain, redness, swelling, and impaired function. After two consecutive clinical examinations an 'activity score' can be determined, ranging from 0 to 10 points. In a retrospective study testing the efficacy of this classification we found that patients with an activity score of 3 or more at the beginning of therapy responded well to anti-inflammatory drugs, while those with a lower activity score mostly did not. Comparing the pretreatment activity score with the degree of enlargement of the extraocular muscles on the CT scan, we found a significant correlation between these two parameters: the higher the activity score, the more the enlargement of the muscles. We conclude that this classification facilitates the proper selection of patients for treatment.
References
- Eur J Clin Invest. 1986 Oct;16(5):415-22
- Trans Am Ophthalmol Soc. 1967;65:41-51
- Am J Ophthalmol. 1977 May;83(5):725-7
- Invest Ophthalmol Vis Sci. 1981 Feb;20(2):173-82
- Am J Ophthalmol. 1985 Jun 15;99(6):633-7
- N Engl J Med. 1983 Feb 24;308(8):453-4
- Acta Ophthalmol (Copenh). 1983 Feb;61(1):108-16
- Endocr Rev. 1984 Spring;5(2):200-20
- Ophthalmology. 1985 May;92(5):657-65
- Ophthalmology. 1981 Jun;88(6):479-83
Source: PubMed